How to diagnose tuberculous (TB) peritonitis clinically and through laboratory tests in a patient with symptoms such as abdominal pain, ascites, and weight loss, and possibly a history of tuberculosis (TB) or immunocompromised status?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis of Tuberculous Peritonitis

Diagnose tuberculous peritonitis by combining clinical suspicion (abdominal pain, ascites, weight loss) with ascitic fluid adenosine deaminase (ADA) levels ≥32-40 U/L in non-cirrhotic patients or ≥27 U/L in cirrhotic patients, which has 100% sensitivity and 96.6-100% specificity, and confirm with laparoscopy and peritoneal biopsy showing caseating granulomas when non-invasive tests are inconclusive. 1, 2

Clinical Presentation

The diagnosis begins with recognizing the characteristic but nonspecific clinical pattern:

Cardinal Symptoms (in order of frequency)

  • Abdominal pain (65-100% of cases) 3, 4, 5
  • Abdominal distension/ascites (91-96% of cases) 4, 5, 6
  • Weight loss (36-82.6% of cases) 3, 4
  • Fever (60-75% of cases) 3, 4, 5
  • Loss of appetite (73-87% of cases) 4, 5

Key Clinical Features

  • Symptoms typically present for 1-12 months before diagnosis (mean 3.1-3.6 months), distinguishing this from acute bacterial peritonitis 4, 7
  • Only 15-19% have abnormal chest X-ray suggesting prior tuberculosis 5, 7
  • Up to 85% have no pulmonary involvement, so absence of lung findings does not exclude the diagnosis 3
  • Tuberculin skin test (purified protein derivative) is usually negative in immunocompromised patients 3

Laboratory Diagnosis

Ascitic Fluid Analysis (First-Line)

Ascitic fluid ADA is the single most useful non-invasive test:

  • ADA ≥32-40 U/L in non-cirrhotic patients: 100% sensitivity, 96.6-100% specificity 1, 2, 8
  • ADA ≥27-32 U/L in cirrhotic patients: 91.7-100% sensitivity, 92-93.3% specificity 1, 2, 8
  • ADA <40 U/L effectively excludes tuberculosis 8

Ascitic Fluid Characteristics

  • Exudative ascites with serum-ascites albumin gradient (SAAG) <1.1 g/dL 4
  • Lymphocyte predominance in ascitic fluid (sensitivity 0-86%) 1, 7
  • Ascitic fluid protein typically elevated 4

Microbiological Tests (Low Yield)

  • Acid-fast bacilli (AFB) smear: only 0-86% sensitivity 1, 2
  • Mycobacterial culture: only 20-83% sensitivity 1, 2
  • PCR for M. tuberculosis DNA: variable results (positive in 9-52% of cases) 4, 9, 7

Critical Pitfall: Do not delay treatment while awaiting culture results given the poor sensitivity of microbiological tests 2

Imaging Findings

CT/Ultrasound Features

  • Free or loculated ascites present in 30-100% of cases 3
  • Variable tomographic density (20-45 Hounsfield units) depending on disease stage 3
  • Multiple mesenteric lymph nodes with peripheral enhancement and central hypodensity 3
  • Lipohydric level in association with necrotic lymph nodes is highly specific for tuberculous ascites 3
  • Omental involvement in 65.2% of cases 4
  • High-density ascites on imaging contributes to diagnosis 7

Important Limitation: CT scan is not sufficiently sensitive or specific alone for diagnosis 3

Definitive Diagnosis: Laparoscopy with Biopsy

When ADA is unavailable or results are equivocal, laparoscopy with directed peritoneal biopsy is the gold standard:

Laparoscopic Findings

  • Scattered yellowish-white nodules (1-5 mm) on peritoneal surfaces with filmy adhesions are pathognomonic 6
  • Laparoscopy suggests tuberculous peritonitis in 95.5% of cases 6
  • Three main presentations: ascitic (most common), plastic/dry (3-4.5%), and glandular 3, 5

Histopathology

  • Caseating granulomas: 76% of biopsies 5
  • Non-caseating granulomas: 20% of biopsies 5
  • Histologic confirmation achieved in 97% of laparoscopic cases 6

Major Complication: Non-fatal colon perforation can occur but is rare 6

Diagnostic Algorithm

Step 1: Clinical Suspicion

  • Patient with chronic abdominal pain, ascites, weight loss, and fever for >1 month 4, 5
  • Consider epidemiology: more common in low-resource settings, immunocompromised patients, and women 3, 4

Step 2: Ascitic Fluid Analysis

  • Perform diagnostic paracentesis immediately 3
  • Measure ADA levels (if available) 1, 2
  • Check cell count with differential (lymphocyte predominance) 1, 7
  • Calculate SAAG (should be <1.1 g/dL) 4
  • Send for AFB smear and culture (despite low yield) 1, 2

Step 3: Imaging

  • CT or ultrasound to identify ascites, lymphadenopathy, and omental involvement 3, 4

Step 4: Definitive Diagnosis

  • If ADA ≥32-40 U/L (or ≥27 U/L in cirrhotics) AND clinical picture consistent: diagnose tuberculous peritonitis 1, 2
  • If ADA unavailable or equivocal: proceed to laparoscopy with peritoneal biopsy 5, 6

Step 5: Exclude Secondary Peritonitis

Differentiate from secondary bacterial peritonitis using:

  • Total protein >1 g/dL, LDH > upper limit of normal, glucose <50 mg/dL (suggests secondary peritonitis) 1
  • Multiple organisms on Gram stain/culture (suggests secondary peritonitis) 1
  • PMN to total leukocyte ratio ≤75% (suggests malignancy rather than bacterial peritonitis) 1

Special Considerations

In Endemic Areas

  • Empiric antituberculosis treatment is recommended for exudative ascites with elevated ADA after excluding malignancy, uremia, trauma, and bacterial peritonitis 2

In Non-Endemic Areas

  • Do not start empiric treatment without stronger diagnostic evidence (lower positive predictive value when prevalence is low) 2

In Resource-Limited Settings

  • Clinical diagnosis supported by basic laboratory tests and ultrasound when CT unavailable 3
  • Tuberculin skin test, radiologic findings, and history of TB exposure contribute to diagnosis when invasive methods unavailable 7

References

Guideline

Cytology Criteria for Diagnosing Peritonitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Tuberculous Peritonitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Tuberculous peritonitis--reports of 26 cases, detailing diagnostic and therapeutic problems.

European journal of gastroenterology & hepatology, 2001

Research

Tuberculous peritonitis in 11 children: clinical features and diagnostic approach.

Pediatrics international : official journal of the Japan Pediatric Society, 1999

Guideline

ADA Levels in Ascitic Fluid for Diagnosing GI Adenocarcinoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

[A case of tuberculous peritonitis].

Kekkaku : [Tuberculosis], 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.